tetano
Editor, Senior Moderator
Clin Pract Cases Emerg Med
. 2021 Feb;5(1):22-25.
doi: 10.5811/cpcem.2020.11.49633.
A Case Report of Cerebral Venous Thrombosis as a Complication of Coronavirus Disease 2019 in a Well-appearing Patient
Monica Logan[SUP] 1 [/SUP], Kyle Leonard[SUP] 1 [/SUP], Daniel Girzadas Jr[SUP] 1 [/SUP]
Affiliations
Abstract
Introduction: While thrombotic complications of severe coronavirus disease 2019 (COVID-19) have been documented, the overall risk in non-critically ill cases of COVID-19 remains unknown.
Case report: We report a case of a previously healthy male patient who presented to the emergency department with headache and extremity paresthesia. The patient was diagnosed with cerebral venous thrombosis (CVT) and found to have a positive COVID-19 test. Inpatient anticoagulation was initiated, and symptoms had largely resolved at discharge.
Conclusion: This case demonstrates the importance of considering thrombotic complications, such as CVT, even in well-appearing COVID-19 patients with no other risk factors for thromboembolic disease.
. 2021 Feb;5(1):22-25.
doi: 10.5811/cpcem.2020.11.49633.
A Case Report of Cerebral Venous Thrombosis as a Complication of Coronavirus Disease 2019 in a Well-appearing Patient
Monica Logan[SUP] 1 [/SUP], Kyle Leonard[SUP] 1 [/SUP], Daniel Girzadas Jr[SUP] 1 [/SUP]
Affiliations
- PMID: 33560945
- DOI: 10.5811/cpcem.2020.11.49633
Abstract
Introduction: While thrombotic complications of severe coronavirus disease 2019 (COVID-19) have been documented, the overall risk in non-critically ill cases of COVID-19 remains unknown.
Case report: We report a case of a previously healthy male patient who presented to the emergency department with headache and extremity paresthesia. The patient was diagnosed with cerebral venous thrombosis (CVT) and found to have a positive COVID-19 test. Inpatient anticoagulation was initiated, and symptoms had largely resolved at discharge.
Conclusion: This case demonstrates the importance of considering thrombotic complications, such as CVT, even in well-appearing COVID-19 patients with no other risk factors for thromboembolic disease.